UCI Health’s medical complex in Orange will be the site of a therapeutic clinical trial for a drug that can treat the coronavirus.
San Dimas-based Gilead Sciences this week said early studies indicate its drug remdesivir showed promise for this purpose; the U.S. FDA could authorize the drug’s use for coronavirus treatment if further clinical tries show effects on recovery time. White House health advisor Dr. Anthony Fauci offered positive comments on the initial data, too.
Other facilities involved in the new round of tests include University of California-San Diego Jacobs Medical Center and University of California-Davis. UCI’s trial is a double-blind study seeking 572 subjects.
For information on the trial, go to ClinicalTrials.gov and search identifier NCT04280705.
Go here for more updates on how OC companies are responding to the coronavirus pandemic.
For ongoing, in-depth coverage of COVID-19’s effects on OC businesses, see the Monday print edition of the Business Journal.
